Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 173 recruiting studies, sorted by proximity — each links to its official registry page
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Mobile, Alabama (4.5 mi)
· Sponsor: Sameek Roychowdhury
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Multiple Myeloma, Secondary Immunodeficiency
Phase 3
Interventional 183 participants sought
Infirmary Health - Diagnostic & Medical Clinic (DMC) — Mobile, Alabama (4.5 mi)
· Sponsor: Takeda
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
Parkinson Disease, Depressive Symptoms
N/A
Interventional 40 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: University of South Alabama
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Usa Mitchell Cancer Institute /ID# 276022 — Mobile, Alabama (4.5 mi)
· Sponsor: AbbVie
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
USA Health Allen Cox Building — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Altesa Biosciences, Inc.
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 160 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Tricuspid Valve Disease
N/A
Interventional 78 participants sought
Springhill Memorial Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Corvivo Cardiovascular, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Infirmary Cancer Care ( Site 0001) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Phase 4
Interventional 150 participants sought
Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Eli Lilly and Company
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: SWOG Cancer Research Network
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Eastern Shore Research Institute — Fairhope, Alabama (16.6 mi)
· Sponsor: Amgen
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 540 participants sought
East View Medical Research /ID# 270377 — Mobile, Alabama (4.5 mi)
· Sponsor: AbbVie
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: NRG Oncology
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Phase 3
Interventional 408 participants sought
Univer South Alabama Ped/Onc — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Southern Cancer Center Pc — Daphne, Alabama (13.7 mi)
· Sponsor: Bristol-Myers Squibb
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Hernia, Ventral, Hernia, Inguinal
N/A
Interventional 160 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Tela Bio Inc
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
End of Life, Cancer
N/A
Interventional 2,996 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Stanford University
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Associates of Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Pacific Edge Limited
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Fairhope, Alabama (16.6 mi)
· Sponsor: AstraZeneca
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Lung Neoplasm Malignant
Phase 2
Interventional 60 participants sought
Southern Cancer Center (SCC) ( Site 8004) — Daphne, Alabama (13.7 mi)
· Sponsor: Merck Sharp & Dohme LLC